Original Research29 December 2015
A Cohort Study
    Author, Article, and Disclosure Information

    Abstract

    Background:

    Nonfatal opioid overdose is an opportunity to identify and treat substance use disorders, but treatment patterns after the overdose are unknown.

    Objective:

    To determine prescribed opioid dosage after an opioid overdose and its association with repeated overdose.

    Design:

    Retrospective cohort study.

    Setting:

    A large U.S. health insurer.

    Participants:

    2848 commercially insured patients aged 18 to 64 years who had a nonfatal opioid overdose during long-term opioid therapy for noncancer pain between May 2000 and December 2012.

    Measurements:

    Nonfatal opioid overdose was identified using International Classification of Diseases, Ninth Revision, Clinical Modification, codes from emergency department or inpatient claims. The primary outcome was daily morphine-equivalent dosage (MED) of opioids dispensed from 60 days before to up to 730 days after the index overdose. We categorized dosages as large (≥100 mg MED), moderate (50 to <100 mg MED), low (<50 mg MED), or none (0 mg MED). Secondary outcomes included time to repeated overdose stratified by daily dosage as a time-varying covariate.

    Results:

    Over a median follow-up of 299 days, opioids were dispensed to 91% of patients after an overdose. Seven percent of patients (n = 212) had a repeated opioid overdose. At 2 years, the cumulative incidence of repeated overdose was 17% (95% CI, 14% to 20%) for patients receiving high dosages of opioids after the index overdose, 15% (CI, 10% to 21%) for those receiving moderate dosages, 9% (CI, 6% to 14%) for those receiving low dosages, and 8% (CI, 6% to 11%) for those receiving no opioids.

    Limitation:

    The cohort was limited to commercially insured adults.

    Conclusion:

    Almost all patients continue to receive prescription opioids after an overdose. Opioid discontinuation after overdose is associated with lower risk for repeated overdose.

    Primary Funding Source:

    Health Resources and Services Administration.

    References

    • 1. Caudill-Slosberg MASchwartz LMWoloshin SOffice visits and analgesic prescriptions for musculoskeletal pain in U.S.: 1980 vs. 2000. Pain2004;109:514-9. [PMID: 15157714] CrossrefMedlineGoogle Scholar
    • 2. Boudreau DVon Korff MRutter CMSaunders KRay GTSullivan MDet alTrends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf2009;18:1166-75. [PMID: 19718704] CrossrefMedlineGoogle Scholar
    • 3. Sullivan MDEdlund MJFan MYDevries ABrennan Braden JMartin BCTrends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP study. Pain2008;138:440-9. [PMID: 18547726] CrossrefMedlineGoogle Scholar
    • 4. Jones CMMack KAPaulozzi LJPharmaceutical overdose deaths, United States, 2010. JAMA2013;309:657-9. [PMID: 23423407] CrossrefMedlineGoogle Scholar
    • 5. Centers for Disease Control and Prevention (CDC)Vital signs: overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morb Mortal Wkly Rep2011;60:1487-92. [PMID: 22048730] MedlineGoogle Scholar
    • 6. Centers for Disease Control and Prevention (CDC)Emergency department visits involving nonmedical use of selected prescription drugs – United States, 2004–2008. MMWR Morb Mortal Wkly Rep2010;59:705-9. [PMID: 20559200] MedlineGoogle Scholar
    • 7. Manchikanti LAbdi SAtluri SBalog CCBenyamin RMBoswell MVet alAmerican Society of Interventional Pain PhysiciansAmerican Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2—guidance. Pain Physician2012;15:S67-116. [PMID: 22786449] MedlineGoogle Scholar
    • 8. Chou RFanciullo GJFine PGAdler JABallantyne JCDavies Pet alAmerican Pain Society-American Academy of Pain Medicine Opioids Guidelines PanelClinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain2009;10:113-30. [PMID: 19187889] CrossrefMedlineGoogle Scholar
    • 9. Dunn KMSaunders KWRutter CMBanta-Green CJMerrill JOSullivan MDet alOpioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med2010;152:85-92. [PMID: 20083827] LinkGoogle Scholar
    • 10. Bohnert ASValenstein MBair MJGanoczy DMcCarthy JFIlgen MAet alAssociation between opioid prescribing patterns and opioid overdose-related deaths. JAMA2011;305:1315-21. [PMID: 21467284] CrossrefMedlineGoogle Scholar
    • 11. Injury Surveillance Workgroup 7. Consensus Recommendations for National and State Poisoning Surveillance. Atlanta, GA: The Safe States Alliance; 2012. Accessed at www.safestates.org/resource/resmgr/imported/ISW7%20Full%20Report_3.pdf on 22 June 2015. Google Scholar
    • 12. Unick GJRosenblum DMars SCiccarone DIntertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993–2009. PLoS One2013;8:e54496. [PMID: 23405084] CrossrefMedlineGoogle Scholar
    • 13. Walley AYXuan ZHackman HHQuinn EDoe-Simkins MSorensen-Alawad Aet alOpioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ2013;346:f174. [PMID: 23372174] CrossrefMedlineGoogle Scholar
    • 14. Von Korff MKorff MVSaunders KThomas Ray GBoudreau DCampbell Cet alDe facto long-term opioid therapy for noncancer pain. Clin J Pain2008;24:521-7. [PMID: 18574361] CrossrefMedlineGoogle Scholar
    • 15. Mattick RPBreen CKimber JDavoli MBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev2014;2:CD002207. [PMID: 24500948] MedlineGoogle Scholar
    • 16. Snapinn SMJiang QIglewicz BIllustrating the impact of a time-varying covariate with an extended Kaplan–Meier estimator. Am Stat2005;59:301-7. CrossrefGoogle Scholar
    • 17. Edlund MJSteffick DHudson THarris KMSullivan MRisk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain2007;129:355-62. [PMID: 17449178] CrossrefMedlineGoogle Scholar
    • 18. Ives TJChelminski PRHammett-Stabler CAMalone RMPerhac JSPotisek NMet alPredictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res2006;6:46. [PMID: 16595013] CrossrefMedlineGoogle Scholar
    • 19. Edlund MJMartin BCFan MYDevries ABraden JBSullivan MDRisks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study. Drug Alcohol Depend2010;112:90-8. [PMID: 20634006] CrossrefMedlineGoogle Scholar
    • 20. Boscarino JARukstalis MHoffman SNHan JJErlich PMGerhard GSet alRisk factors for drug dependence among out-patients on opioid therapy in a large U.S. health-care system. Addiction2010;105:1776-82. [PMID: 20712819] CrossrefMedlineGoogle Scholar
    • 21. Centers for Disease Control and Prevention (CDC)Overdose deaths involving prescription opioids among Medicaid enrollees – Washington, 2004–2007. MMWR Morb Mortal Wkly Rep2009;58:1171-5. [PMID: 19875978] MedlineGoogle Scholar
    • 22. Bohnert ASIlgen MAGalea SMcCarthy JFBlow FCAccidental poisoning mortality among patients in the Department of Veterans Affairs Health System. Med Care2011;49:393-6. [PMID: 21407033] CrossrefMedlineGoogle Scholar
    • 23. Garcia AMState laws regulating prescribing of controlled substances: balancing the public health problems of chronic pain and prescription painkiller abuse and overdose. J Law Med Ethics2013;41 Suppl 1:42-5. [PMID: 23590739] CrossrefMedlineGoogle Scholar
    • 24. Daubresse MGleason PPPeng YShah NDRitter STAlexander GCImpact of a drug utilization review program on high-risk use of prescription controlled substances. Pharmacoepidemiol Drug Saf2014;23:419-27. [PMID: 23881609] doi:10.1002/pds.3487 CrossrefMedlineGoogle Scholar